Search results
IPC Develops Consensus on Generalized Pustular Psoriasis
Medscape· 20 hours agoThe IPC's definition and diagnostic criteria for GPP minimized the complexity of clinical...
VYNE Therapeutics receives FDA approval for trial of VYN202
Clinical Trials Arena via Yahoo Finance· 2 days agoThe company expects to report top-line results from the ...BD2 inhibition and optimal oral...
Amjevita and dosage: Strengths, forms, how to inject, and more
Medical News Today· 6 days agoAmjevita comes as a solution subcutaneous injection. Your doctor will determine the best dosage to...
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 16 hours agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar ...
Protagonist Reports First Quarter 2024 Financial Results and Provides Corporate Update
Morningstar· 1 day agoEntered into a worldwide license and collaboration agreement for rusfertide with Takeda; Cash runway extended through Q4 2027[1]Enrollment in both Phase 3 ICONIC LEAD and ICONIC TOTAL trials ...
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
InvestorPlace· 1 day agoInvestors concerned about broader market undulations may want to consider the resilience narrative...
Siliq and cost: Reducing long-term drug costs and more
Medical News Today· 6 days agoSiliq’s cost with and without insurance can depend on several factors, such as whether Siliq has a...
Janssen-Cilag seeks expanded EMA approval for TREMFYA
Pharmaceutical Technology via Yahoo Finance· 7 days agoTreatment with guselkumab also offered statistically significant and clinically meaningful...
3 Tried and True Dividend Stocks to Buy for Your Portfolio
InvestorPlace· 1 day agoPicking income stocks can be challenging. It varies year to year, but holding solid income stocks...
FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo
Medscape· 7 days agoUnlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation.